Chemical formula: C₈H₁₂N₄O₅ Molecular mass: 244.205 g/mol PubChem compound: 37542
Ribavirin is a synthetic nucleoside analogue which has shown in vitro activity against some RNA and DNA viruses. The mechanism by which ribavirin in combination with other medicinal products exerts its effects against HCV is unknown.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| J05AP01 | J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AP Antivirals for treatment of HCV infections | |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| VIRAZOLE Inhalation solution | FDA, National Drug Code (US) | MPI, US: SPL/Old | |
| REBETOL Hard capsule | European Medicines Agency (EU) | MPI, EU: SmPC |
Ribavirin is an active ingredient of these brands:
Australia (AU)Austria (AT)Brazil (BR)Cyprus (CY)Finland (FI)France (FR)Ireland (IE)Italy (IT)Japan (JP)Mexico (MX)Netherlands (NL)Spain (ES)United Kingdom (UK)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
